Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Kidney Neoplasms 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Endocrine Gland Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1

Interventions

Magnetic Resonance Spectroscopy 11 trametinib 7 Nivolumab 7 selpercatinib 6 pembrolizumab 6 dabrafenib 6 Iodine-131 6 Specimen Handling 5 Biopsy 5 lenvatinib 4 Vemurafenib 4 Iodine-124 4 durvalumab 3 cabozantinib 3 binimetinib 3 Ipilimumab 3 Immunoglobulin G 3 Fluorodeoxyglucose F18 3 Disulfides 3 Cyclophosphamide 3 Cetuximab 3 vandetanib 2 ulixertinib 2 omipalisib 2 larotrectinib 2 defactinib 2 copanlisib 2 cemiplimab 2 anlotinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × Biopsy, Large-Core Needle × 1 year × Clear all

NCT07419932 2026-02-19

NeoLATC

Fujian Medical University

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡